Court Bars Four Generic Firms From Selling Generic Versions of Glaucoma Rx Combigan

The applications of four different companies to make and sell generic copies of Allergan Inc.'s glaucoma medicine Combigan (brimonidine tartrate/timolol maleate ophthalmic solution 0.2 percent/0.5 percent) infringe four Allergan patents covering the drug, a federal district court ruled Aug. 25 (Allergan Inc. v. Sandoz Inc.).

In a final judgment and injunction entered Aug. 25, Judge T. John Ward of the U.S. District Court for the Eastern District of Texas enjoined generic drug company defendants Sandoz Inc., Alcon Inc., Apotex Inc., and Watson Laboratories Inc. from entering the market with generic Combigan copies before the patents in suit and ...